20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is DILTIAZEM HCL, with a corresponding US DMF Number 5717.
Remarkably, this DMF maintains an Active status since its submission on February 06, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 01, 2017, and payment made on December 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II